Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY23 results · Jan–Mar 2023
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹883.09 crore (down 9.3% from Q4 FY22) and net profit of ₹165.02 crore (up 60.4% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 883.09 | 973.26 | −9.3% | 1,137.39 | −22.4% |
| Other income | 14.44 | 6.03 | +139.5% | 9.31 | +55.1% |
| Total income | 897.53 | 979.29 | −8.3% | 1,146.70 | −21.7% |
| Profit before tax | 145.56 | 151.10 | −3.7% | 281.53 | −48.3% |
| Net profit for the period | 165.02 | 102.85 | +60.4% | 207.47 | −20.5% |
| EPS, basic (₹) | 50.84 | 31.68 | +60.5% | 63.91 | −20.5% |
| Net margin (%) | 18.7 | 10.6 | 18.2 |
Standalone
- Filed with BSE
- 11 May 2023, 14:59 IST
- Board meeting
- 10 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE